BMO Capital Downgrades BioMed Realty (BMR) to Market Perform, Cuts Price Target to $19

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. SNDK
6. GNK
7. HTFL
8. ADYEN:NA
9. DVLT
10. ADYYF

January 3, 2012 11:44 AM EST
Get Alerts BMR Hot Sheet
Price: $1.32 +3.94%

Rating Summary:
    6 Buy, 8 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
BMO Capital downgraded shares of BioMed Realty (NYSE: BMR) to a Market Perform rating from its previous rating of Outperform. The firm also reduced its price target from $22 to $19 on the shares.

For an analyst ratings summary and ratings history on BioMed Realty click here. For more ratings news on BioMed Realty click here.

Shares of BioMed Realty closed at $18.08 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Downgrades

Related Entities

BMO Capital